Jumpcode Genomics
PrivateLast Round
Grant
Feb 20, 2025
Total Funding Raised
$37.39M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Jumpcode Genomics is a biotechnology company that develops and commercializes CRISPR-based technology for next-generation sequencing (NGS) to improve data sensitivity and simplify workflows.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Jumpcode Genomics Comparables
Compare Jumpcode Genomics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SeqWell | 85% | |
| siTOOLs Biotech GmbH | 84% | |
| Watchmaker Genomics | 81% |
Jumpcode Genomics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 20, 2025 | ||||
| VC Round | Aug 21, 2024 | ||||
| Series B Extension | Apr 27, 2023 | ||||
| VC Round | Sep 21, 2022 | ||||
| Series B | Jan 12, 2021 | ||||
Series A | Feb 11, 2020 |
Jumpcode Genomics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| LYZZ Capital | Series B, Seed |
| Arboretum Ventures | Series B |
| Baird Capital | Series B |
| European Health and Digital Executive Agency | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 29, 2026
Monthly visitors grew 66% MoM, reaching 1.3K.
- May 16, 2026
Monthly visitors grew 68% MoM, reaching 1.4K.
Jumpcode Genomics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Jumpcode Genomics's valuation, stock price, and market status.
Is Jumpcode Genomics a public or private company?
Jumpcode Genomics is a private company.
What is the current stock price of Jumpcode Genomics?
Jumpcode Genomics is a private company, so its shares have no public market price. Caplight tracks Jumpcode Genomics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Jumpcode Genomics worth (valuation)?
Valuation information for Jumpcode Genomics is not publicly available.
Can I buy Jumpcode Genomics stock?
Jumpcode Genomics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Jumpcode Genomics's last funding round?
Jumpcode Genomics's most recent funding round was Grant on February 20, 2025.
Who are the main investors in Jumpcode Genomics?
Key investors in Jumpcode Genomics include Arboretum Ventures, Baird Capital.
Will Jumpcode Genomics IPO soon?
No public IPO plans have been announced for Jumpcode Genomics.
How can I track Jumpcode Genomics secondary market activity?
Caplight tracks bids, offers, and trades in Jumpcode Genomics's shares on secondary markets.